ClariMedClariMed
Recherchen nahtlos fortsetzen
30 Sek mit Email - kein Passwort, kein Formular. Ihr Verlauf bleibt auf jedem Gerät.

Verlauf

Keine Anfragen

Cochrane2023IaEN

Cochrane Review: Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD)

Zusammenfassung

Pharmakologische Interventionen gegen Reizbarkeit, Aggressivität und Selbstverletzung bei Autismus‐Spektrum‐Störungen (ASS) - Iffland, M - 2023 \| Cochrane Library [Skip to Content](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011769.pub2/full/de#main-content) [Close cookies message](https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011769.pub2/full/de#) Cookies Our site uses cookies to improve your experience. You can find out more about our use of cookies in About

Kerninformationen

51858.CD011769.pub2/full/de#) [Cochrane Database of Systematic reviews](https://www.cochranelibrary.com/en/about/about-cochrane-reviews) Review - Intervention Collapse all Expand all ## Abstract available in ### Background Pharmacological interventions are frequently used for people with auti...
ers up to June 2022. We also searched reference lists of relevant studies, and contacted study authors, experts and pharmaceutical companies. ### Selection criteria We included randomised controlled trials of participants of any age with a clinical diagnosis of ASD, that compared any pharmacologic...
We included 131 studies involving 7014 participants in this review. We identified 26 studies as awaiting classification and 25 as ongoing. Most studies involved children (53 studies involved only children under 13 years), children and adolescents (37 studies), adolescents only (2 studies) children a...
Originaldokument ansehen

Fragen zu diesem Thema?

ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.

Jetzt auf ClariMed suchen

Verwandte Leitlinien